Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
LENSAR (LNSR)
NASDAQ:LNSR
LNSR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.67 - $12.13
Previous CloseN/A
Volume40.10K
Average Volume (3M)92.15K
Market Cap
$114.87M
Enterprise Value$50.74M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.39
Next Earnings
Feb 27, 2025EPS Estimate
-0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.46
Shares Outstanding11,614,807
10 Day Avg. Volume74,170
30 Day Avg. Volume92,147
Standard Deviation0.19
R-Squared0.03
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.48
Price to Cash Flow (P/CF)9.60
P/FCF Ratio9.70
Enterprise Value/Market Cap0.44
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.40
Enterprise Value/Ebitda-8.71
Forecast
1Y Price Target
$12.00Price Target Upside21.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
LENSAR News
PremiumCompany Announcements
LENSAR Inc. Reports Strong Q3 2024 Growth
PremiumCompany Announcements
LENSAR Ends Ophthalmic Device Agreement with Oertli Instrumente
---
Bulls Say, Bears Say
Bulls Say
Market Share GrowthDemand for the ALLY system was extremely strong, leading to a significant market share growth in 3Q24.
UndervaluationDespite the momentum and favorable outlook, shares trade at 2x ’25 EV/Rev vs. pure-play ophthalmology at ~6x, indicating undervaluation.
Bears Say
ProfitabilityGross margins are lower due to higher capital sales, which impacts the company's profitability.
---
Ownership Overview
40.41% Insiders
9.52% Mutual Funds
15.30% Other Institutional Investors
30.31% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
LNSR FAQ
What was LENSAR’s price range in the past 12 months?
LENSAR lowest stock price was $2.67 and its highest was $12.13 in the past 12 months.
What is LENSAR’s market cap?
LENSAR’s market cap is $114.87M.
When is LENSAR’s upcoming earnings report date?
LENSAR’s upcoming earnings report date is Feb 27, 2025 which is in 5 days.
How were LENSAR’s earnings last quarter?
LENSAR released its earnings results on Nov 07, 2024. The company reported -$0.13 earnings per share for the quarter, beating the consensus estimate of -$0.294 by $0.164.
Is LENSAR overvalued?
According to Wall Street analysts LENSAR’s price is currently Undervalued.
Does LENSAR pay dividends?
LENSAR does not currently pay dividends.
What is LENSAR’s EPS estimate?
LENSAR’s EPS estimate is -0.18.
How many shares outstanding does LENSAR have?
LENSAR has 11,614,807 shares outstanding.
What happened to LENSAR’s price movement after its last earnings report?
LENSAR reported an EPS of -$0.13 in its last earnings report, beating expectations of -$0.294. Following the earnings report the stock price went up 17.235%.
Which hedge fund is a major shareholder of LENSAR?
Currently, no hedge funds are holding shares in LNSR
---
LENSAR Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.00 (21.33% Upside)
$12.00 (21.33% Upside)
Blogger Sentiment
Bullish
LNSR Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
109.53%
12-Months-Change
Fundamentals
Return on Equity
-38.38%
Trailing 12-Months
Asset Growth
-12.47%
Trailing 12-Months
Company Description
LENSAR
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts.
---
LNSR Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call was generally positive, highlighting significant growth in system placements, revenue, and market share. The expansion into new markets and strong recurring revenue growth were particularly noteworthy. However, challenges such as a decreased gross margin and a net loss for the quarter were also acknowledged.Read More>---
LNSR Stock 12 Month Forecast
Average Price Target
$12.00
▲(21.33% Upside)
Technical Analysis
Align Tech
―
ICU Medical
―
EyePoint Pharmaceuticals
―
Staar Surgical
―
National Vision Holdings
―
Best Analysts Covering LNSR
1 Year
1 Year Success Rate
9/15 ratings generated profit
1 Year Average Return
+25.45%
reiterated a buy rating 4 months ago
Copying Ryan Zimmerman's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +25.45% per trade.
---